Sodium (±)‐5‐bromo‐2‐(α‐hydroxypentyl) benzoate ameliorates pressure overload‐induced cardiac hypertrophy and dysfunction through inhibiting autophagy

Sodium (±)‐5‐bromo‐2‐(a‐hydroxypentyl) benzoate (generic name: brozopine, BZP) has been reported to protect against stroke‐induced brain injury and was approved for Phase II clinical trials for treatment of stroke‐related brain damage by the China Food and Drug Administration (CFDA). However, the ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Shen, Deliang, Tang, Junnan, Li, Jing, Xiao, Yue, Chen, Xiuying, Cao, Chang, Han, Dongjian, Gao, Erhe, Zhao, Wen, Zhang, Jinying, Chang, Junbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714213/
https://www.ncbi.nlm.nih.gov/pubmed/31222939
http://dx.doi.org/10.1111/jcmm.14468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714213/
https://www.ncbi.nlm.nih.gov/pubmed/31222939
http://dx.doi.org/10.1111/jcmm.14468

Ejemplares similares